CD274 and non-small cell lung carcinoma: The frequency of PD-L1 positivity seen in our material (≥1% positive tumor cells in approximately 66% of NSQ and 74% of SQ) is in line with or slightly higher than other large real-world studies from Europe and North America showing a prevalence of 52–63% in NSCLC [14–17].